Axsome Therapeutics reported strong financial results and progress in advancing innovative medicines. The company plans to expand its sales force for Auvelity and is optimistic about potential growth in various therapeutic areas. Key milestones include upcoming data readouts for Alzheimer's disease agitation and migraine.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing